<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">BAS</journal-id><journal-title-group><journal-title>Bone and Arthrosurgery Science</journal-title></journal-title-group><issn>3083-4856</issn><eissn>2981-8222</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/bas.v3i6.13316</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>Clinical Guideline for Perioperative Pain Management in Diabetic Foot Ulcers</title><url>https://artdesignp.com/journal/BAS/3/6/10.26689/bas.v3i6.13316</url><author>ZongJunwei,FanShubo,GaoLei,ZhaoTianqi,ZhangZhen,WangShouyu</author><pub-date pub-type="publication-year"><year>2025</year></pub-date><volume>3</volume><issue>6</issue><history><date date-type="pub"><published-time>2025-12-31</published-time></date></history><abstract>This guideline outlines the pathophysiology and classification of neuropathic, ischemic, inflammatory, and procedural pain, and proposes a risk-stratified assessment using NRS/VAS combined with ulcer severity and comorbidities. Core recommendations emphasize preventive multimodal analgesia, prioritization of regional anesthesia, systematic management of neuropathic pain, protocolized procedural analgesia, and multidisciplinary collaboration.</abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>Armstrong DG, Boulton AJM, Bus SA, 2017, Diabetic Foot Ulcers and Their Recurrence. The New England Journal of Medicine, 376(24): 2367–2375.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>Blume PA, Walters J, Payne W, et al., 2008, Comparison of Negative Pressure Wound Therapy Using Vacuum-Assisted Closure with Advanced Moist Wound Therapy in the Treatment of Diabetic Foot Ulcers: A Multicenter Randomized Controlled Trial. Diabetes Care, 31(4): 631–636.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Bril V, England J, Franklin GM, et al., 2011, Evidence-Based Guideline: Treatment of Painful Diabetic Neuropathy. Neurology, 76(20): 1758–1765.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Bus SA, Armstrong DG, Gooday C, et al., 2020, Guidelines on Offloading Foot Ulcers in Persons with Diabetes (IWGDF 2019 Update). Diabetes/Metabolism Research and Reviews, 36(Suppl 1): e3274.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Chou R, Gordon DB, de Leon-Casasola OA, et al., 2016, Management of Postoperative Pain: A Clinical Practice Guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists’ Committee on Regional Anesthesia, Executive Committee, and Administrative Council. The Journal of Pain, 17(2): 131–157.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><p>Dumville JC, Owens GL, Crosbie EJ, et al., 2013, Negative Pressure Wound Therapy for Treating Foot Ulcers in People with Diabetes Mellitus. Cochrane Database of Systematic Reviews, (10): CD010318.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><p>Dworkin RH, O’Connor AB, Backonja M, et al., 2007, Pharmacologic Management of Neuropathic Pain: Evidence-Based Recommendations. Pain, 132(3): 237–251.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B8" content-type="article"><label>8</label><element-citation publication-type="journal"><p>Finnerup NB, Attal N, Haroutounian S, et al., 2015, Pharmacotherapy for Neuropathic Pain in Adults: A Systematic Review and Meta-Analysis. The Lancet Neurology, 14(2): 162–173.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B9" content-type="article"><label>9</label><element-citation publication-type="journal"><p>Game FL, Attinger C, Hartemann H, et al., 2016, IWGDF Guidance on Use of Interventions to Enhance the Healing of Chronic Ulcers of the Foot in Diabetes. Diabetes/Metabolism Research and Reviews, 32(Suppl 1): 75–83.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B10" content-type="article"><label>10</label><element-citation publication-type="journal"><p>Noble M, Treadwell JR, Tregear SJ, et al. Long-Term Opioid Management for Chronic Noncancer Pain. Cochrane Database of Systematic Reviews. 2010(1): CD006605.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B11" content-type="article"><label>11</label><element-citation publication-type="journal"><p>Pop-Busui R, Boulton AJM, Feldman EL, et al., 2017, Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care, 40(1): 136–154.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B12" content-type="article"><label>12</label><element-citation publication-type="journal"><p>Prompers L, Huijberts M, Apelqvist J, et al., 2007, High Prevalence of Ischaemia, Infection and Serious Comorbidity in Patients with Diabetic Foot Disease in Europe: Baseline Results from the Eurodiale Study. Diabetologia, 50(1): 18–25.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B13" content-type="article"><label>13</label><element-citation publication-type="journal"><p>Treede R-D, Jensen TS, Campbell JN, et al., 2008, Neuropathic Pain: Redefinition and a Grading System for Clinical and Research Purposes. Neurology, 70(18): 1630–1635.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B14" content-type="article"><label>14</label><element-citation publication-type="journal"><p>Tesfaye S, Boulton AJM, Dyck PJ, et al., 2010, Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments. Diabetes Care, 33(10): 2285–2293.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B15" content-type="article"><label>15</label><element-citation publication-type="journal"><p>Schaper NC, Van Netten JJ, Apelqvist J, et al., 2020, Practical Guidelines on the Prevention and Management of Diabetic Foot Disease (IWGDF 2019 Update). Diabetes/Metabolism Research and Reviews, 36(Suppl 1): e3266.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B16" content-type="article"><label>16</label><element-citation publication-type="journal"><p>Woo KY, Sibbald RG, Fogh K, et al., 2008, Assessment and Management of Persistent (Chronic) Wound Pain: A Consensus. International Wound Journal, 5(2): 159–177.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B17" content-type="article"><label>17</label><element-citation publication-type="journal"><p>Zhang P, Lu J, Jing Y, et al., 2017, Global Epidemiology of Diabetic Foot Ulceration: A Systematic Review and Meta-Analysis. Annals of Medicine, 49(2): 106–116.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B18" content-type="article"><label>18</label><element-citation publication-type="journal"><p>Lipsky BA, Senneville E, Abbas ZG, et al., 2020, Guidelines on the Diagnosis and Treatment of Foot Infection in Persons with Diabetes (IWGDF 2019 Update). Diabetes/Metabolism Research and Reviews, 36(Suppl 1): e3280.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
